NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
17/10/2024
Voltar para busca
Dado oficial do USPTO
ANTIDOTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
17/10/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 42, 44
Data de depósito
16/08/2016
Data de registro
31/10/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/10/2024
Última transação
17/10/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
19/09/2016
Primeiro uso no comércio
19/09/2016
Código do desenho
3
Tipo de titular
99
Localização do titular
LONDON, GB
Examinador
MARSH,BRANDON N
Localização atual
Historical data usage
Descrição da marca
The mark consists of the word "antidote" in lower case letters followed by a three-line design.
Titulares e representantes
Titulares
ANTIDOTE TECHNOLOGIES LTD.
TrialReach Ltd.
Representantes
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Recruiting subjects for clinical healthcare trials
Classe 42
Software as a service (SaaS) services, namely, hosting software for use by others for use in database management and patient referrals for clinical trials; providing temporary use of online nondownloadable computer software for management of clinical trials, measuring and monitoring the performance of clinical trials, for identifying and recruiting patients for participation in clinical trials, and for matching patients with clinical trials; providing medical and scientific research information in the field of clinical trials; providing the service of matching individuals with clinical trials; providing clinical trial data and patient data, and analysis of such data, all for use in clinical trial planning and recruitment of patients for clinical trials, and for pharmaceutical development; cloud computing featuring software for use in analyzing clinical trial data and patient data in connection with medical and scientific research, clinical trial planning and pharmaceutical development; providing internet search engines; providing a website featuring a search engine that enables patients to discover, connect with and participate in clinical trials; providing a website featuring medical and scientific research information related to clinical trials for the treatment of various conditions
Classe 44
Providing a website featuring health and health care information for patients seeking medical treatment through participation in clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
17/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
22/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/06/2023
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
05/01/2023
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
05/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2023
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/01/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/10/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/10/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/10/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/09/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
26/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
26/09/2017
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
26/09/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/02/2017
GNRT
NON-FINAL ACTION E-MAILED
26/02/2017
CNRT
SU - NON-FINAL ACTION - WRITTEN
26/02/2017
DOCK
ASSIGNED TO EXAMINER
04/02/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
29/12/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/12/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/12/2016
IUAF
USE AMENDMENT FILED
06/12/2016
EISU
TEAS STATEMENT OF USE RECEIVED
06/12/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/12/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/10/2016
PUBO
PUBLISHED FOR OPPOSITION
11/10/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2016
DOCK
ASSIGNED TO EXAMINER
03/09/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
20/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2016
NWAP
NEW APPLICATION ENTERED
19/08/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ANTIDOTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.